The Centers for Medicare & Medicaid Services will reweight the cost performance category for the Merit-based Incentive Payment System from 15% to 0% for the 2020 performance period — which affects 2022 payments — due to the impact of the COVID-19 public health emergency, and redistribute the 15% prescribed weight to another performance category or categories. 

“Our analysis of the underlying data for the 2020 performance year, in comparison to prior years’ data, shows that the volume of data available to calculate the scores for the cost measures has significantly decreased overall,” CMS said. “As a result, we do not believe we can reliably calculate scores for the cost measures that would adequately capture and reflect the performance of MIPS eligible clinicians.”

Because the cost performance category relies on administrative claims data, clinicians do not need to take any action, CMS said. For more on the Quality Payment Program, visit the QPP website
 

Related News Articles

Headline
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
The National Academy for State Health Policy’s Hospital Cost Tool “misses the mark in many ways, and its use by payers, purchasers and policymakers could have…
Perspective
There will always be administrative costs associated with operating a hospital. But the lion’s share of a hospital’s resources should be devoted to doing what…
Blog
Last week, several academics released a working paper saying hospital prices lead to employment losses outside the health sector, among other faulty…
Headline
The Department of Health and Human Services June 24 released a final rule that would disincentivize health care providers for interfering with the access,…
Perspective
Hospitals hold an extraordinary place in our society by offering comfort and caring to all who walk through their doors, regardless of ability to pay.While the…